Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
First People's Hospital of Hangzhou
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed stage IIIB/IV NSCLC;
Patient had received ≤ 1 prior systemic chemotherapy regimens;
Provision of blood (plasma) sample for ctDNA testing;
Patient must be able to comply with the protocol;
You may not be if
Prior received ≥2 systemic chemotherapy regimens;
As judged by the investigator, any evidence of severe or uncontrolled systemic disease (e.g. unstable or uncompensated respiratory, cardiac, hepatic or renal disease);
Histologically confirmed small cell lung cancer or other metastatic tumors;
Patient with no histologic or cytological diagnosis;
Clareo Health | EGFR Mutations on ctDNA in Patients With Advanced NSCLC
